Remove Development Remove Ethics Remove Finance Remove Pharmaceuticals
article thumbnail

Introducing 100 Coaches: Pay It Forward Champions

Marshall Goldsmith

14th Administrator, United States Agency for International Development. Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team. HR and talent development roles with General Motors Australia. Darek Lenart – Senior VP HR, Finance MasterCard.

article thumbnail

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Harvard Business Review

Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. Commonly, researchers develop a theory, then build a career gathering support for it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.

article thumbnail

The “Maximize Profits” Trap in Decision Making

Harvard Business Review

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. How should you make this decision?

ROI 8